Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 3
2014 5
2015 9
2016 7
2017 5
2018 2
2019 1
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.
Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Zappa M, Nelen V, Kwiatkowski M, Lujan M, Määttänen L, Lilja H, Denis LJ, Recker F, Paez A, Bangma CH, Carlsson S, Puliti D, Villers A, Rebillard X, Hakama M, Stenman UH, Kujala P, Taari K, Aus G, Huber A, van der Kwast TH, van Schaik RH, de Koning HJ, Moss SM, Auvinen A; ERSPC Investigators. Schröder FH, et al. Lancet. 2014 Dec 6;384(9959):2027-35. doi: 10.1016/S0140-6736(14)60525-0. Epub 2014 Aug 6. Lancet. 2014. PMID: 25108889 Free PMC article. Clinical Trial.
Active surveillance: oncologic outcome.
Venderbos LD, Bokhorst LP, Bangma CH, Roobol MJ. Venderbos LD, et al. Among authors: bokhorst lp. Curr Opin Urol. 2013 May;23(3):268-72. doi: 10.1097/MOU.0b013e32835efe8f. Curr Opin Urol. 2013. PMID: 23425994 Review.
Active surveillance for prostate cancer: a narrative review of clinical guidelines.
Bruinsma SM, Bangma CH, Carroll PR, Leapman MS, Rannikko A, Petrides N, Weerakoon M, Bokhorst LP, Roobol MJ; Movember GAP3 consortium. Bruinsma SM, et al. Among authors: bokhorst lp. Nat Rev Urol. 2016 Mar;13(3):151-67. doi: 10.1038/nrurol.2015.313. Epub 2016 Jan 27. Nat Rev Urol. 2016. PMID: 26813955 Review.
[Couching then and now].
Bokhorst LP, Zegers RH. Bokhorst LP, et al. Ned Tijdschr Geneeskd. 2011;155:A3283. Ned Tijdschr Geneeskd. 2011. PMID: 21649948 Dutch.
The ProtecT trial: what can we expect?
Roobol MJ, Bokhorst LP. Roobol MJ, et al. Among authors: bokhorst lp. Lancet Oncol. 2014 Sep;15(10):1046-7. doi: 10.1016/S1470-2045(14)70198-6. Epub 2014 Aug 19. Lancet Oncol. 2014. PMID: 25163904 Free article. No abstract available.
Reply from authors re: Michael Baum. Screening for prostate cancer: can we learn from the mistakes of the breast screening experience? Eur Urol 2013;64:540-1: screening for prostate cancer: we have learned and are still learning.
Roobol MJ, Kranse R, Bangma CH, Otto SJ, van der Kwast TH, Bokhorst LP, de Koning HJ, Schröder FH. Roobol MJ, et al. Among authors: bokhorst lp. Eur Urol. 2013 Oct;64(4):541-3. doi: 10.1016/j.eururo.2013.06.033. Epub 2013 Jun 26. Eur Urol. 2013. PMID: 23816273 No abstract available.
29 results